EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis

Jie Yao, Changshuai Zhou, Liren Ding iD

PLOS One · 12.06.2026 · 21 (6) · e0351622

DOI: 10.1371/journal.pone.0351622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 12.06.2026. Verfasst von Jie Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Macrophages, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung adenocarcinoma (LUAD) is a predominant subtype of lung cancer associated with an unfavorable prognosis. However, the roles of the tumor microenvironment (TME) and Kynureninase (KYNU) in LUAD remain largely unclear. This study aimed to investigate the potential role of KYNU in macrophages and LUAD.

Methods

All LUAD related data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The expression of KYNU was analyzed across different cell types following dimensionality reduction analysis. Immune cell infiltration and immunotherapy response prediction were performed using CIBERSORT and TIMER, respectively. Gene set variation analysis (GSVA) was employed for functional enrichment.

Results

Among all immune cells in LUAD, KYNU was primarily expressed in monocytes and macrophages. The upregulated genes in KYNU+macrophages group were significantly enriched in in gene ontology (GO) terms related to antigen processing and presentation. There were increased MHC-I/ MHC-II signal interactions between KYNU+macrophages and B cells as well as T cells. In LUAD patients with higher proportions of KYNU+macrophages, a significantly greater number of patients benefited from immunotherapy ( p = 0.033). GSVA results indicated that the MHC pathway was significantly activated in high KYNU+macrophage group.

Conclusions

KYNU is primarily in LUAD macrophages, contributing to the distinct immune features and correlating with the enhanced antigen presentation in LUAD. This study preliminarily confirms that KYNU may serve as a potential biomarker for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesLung NeoplasmsAdenocarcinoma of LungHumansTumor MicroenvironmentSequence Analysis, RNAGene Expression Regulation, NeoplasticSingle-Cell Analysis

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Cardiothoracic, The Fourth Affiliated Hospital Zhejiang University School of Medicine, Yiwu, China.
  • Department of Respiratory Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Liren Ding

Zitieren

APA

Yao, J., Zhou, C., & Ding, L. (2026). KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis. PLOS One, 21(6), e0351622. https://doi.org/10.1371/journal.pone.0351622

Vancouver

Yao J, Zhou C, Ding L. KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis. PLOS One. 2026;21(6):e0351622. doi:10.1371/journal.pone.0351622

BibTeX
@article{Yao2026,
  author = {Yao, Jie and Zhou, Changshuai and Ding, Liren},
  title = {KYNU in macrophages contributes to the unique immune feature of LUAD via integrating single-cell and bulk RNA sequencing data: an exploratory analysis},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0351622},
  doi = {10.1371/journal.pone.0351622}
}
Kostenlos starten →